The 5' binding MID domain of human Argonaute2 tolerates chemically modified nucleotide analogues.
Deleavey GF, Frank F, Hassler M, Wisnovsky S, Nagar B, Damha MJ. The 5' binding MID domain of human Argonaute2 tolerates chemically modified nucleotide analogues. Nucleic Acid Ther. 2013 Feb; 23(1):81-7.